Kris Doggen
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiac Fibrosis and Remodeling
- Cardiovascular Function and Risk Factors
-
- Diabetic Foot Ulcer Assessment and Management
- Diabetes Treatment and Management
- Diabetes Management and Research
Papers in
-
- Diabetic Foot Ulcer Assessment and Management 6
-
- Cardiac Fibrosis and Remodeling 3
- Chemotherapy-induced cardiotoxicity and mitigation 2
- Co-authors
- Gilles W. De Keulenaer (7 shared papers)Katrien Lemmens (6 shared papers)Marina Trento (1 shared paper)Agnieszka Pazderska (1 shared paper)Guy E.H.M. Rutten (1 shared paper)John J. Nolan (1 shared paper)G. Charpentier (1 shared paper)Oliver Kuß (1 shared paper)
- Journals
- Diabetes/Metabolism Research and Reviews (2 papers)European Journal of Public Health (2 papers)European Journal of Pediatrics (1 paper)PharmacoEconomics (1 paper)PLoS ONE (1 paper)
- Partner nations
- BelgiumUnited StatesUnited Kingdom
In The Last Decade
Kris Doggen
25 papers receiving 847 citations
Peers
Comparison fields: 5 of 80
- Cardiology and Cardiovascular Medicine 319
- Endocrinology, Diabetes and Metabolism 205
- Oncology 203
- Occupational Therapy 19
- Rehabilitation 27
Countries citing papers authored by Kris Doggen
This map shows the geographic impact of Kris Doggen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kris Doggen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kris Doggen more than expected).
Fields of papers citing papers by Kris Doggen
This network shows the impact of papers produced by Kris Doggen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kris Doggen. The network helps show where Kris Doggen may publish in the future.
Co-authors
The 25 scholars most cited alongside Kris Doggen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 218 | |
| 2 | 2013 | 206 | |
| 3 | 2010 | 159 | |
| 4 | 2010 | 64 | |
| 5 | 2004 | 32 | |
| 6 | 2018 | 31 | |
| 7 | 2015 | 29 | |
| 8 | 2008 | 26 | |
| 9 | 2014 | 18 | |
| 10 | 2023 | 16 | |
| 11 | 2014 | 14 | |
| 12 | 2019 | 9 | |
| 13 | 2013 | 9 | |
| 14 | 2012 | 7 | |
| 15 | 2011 | 6 | |
| 16 | Neuregulin-1 and its potential role in the control of cardiac function. | 2008 | 5 |
| 17 | 2022 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2022 | 2 |
About Kris Doggen
Kris Doggen is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Oncology, Molecular Biology and Epidemiology, having authored 25 papers that have together received 867 indexed citations. Recurring topics across this work include Diabetic Foot Ulcer Assessment and Management (6 papers), HER2/EGFR in Cancer Research (4 papers), Cardiac Fibrosis and Remodeling (3 papers), Peptidase Inhibition and Analysis (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Cancer Treatment and Pharmacology (2 papers), Obesity, Physical Activity, Diet (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (319 citations), Endocrinology, Diabetes and Metabolism (205 citations), Oncology (203 citations), Occupational Therapy (19 citations) and Rehabilitation (27 citations). Kris Doggen has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Gilles W. De Keulenaer, Katrien Lemmens, Marina Trento, Agnieszka Pazderska, Guy E.H.M. Rutten, John J. Nolan, G. Charpentier, Oliver Kuß, Margaret Stone and Kamlesh Khunti. Their work appears in journals such as Diabetes/Metabolism Research and Reviews, European Journal of Public Health, European Journal of Pediatrics, PharmacoEconomics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.